DIXON DONALD R sold $765K of AMPX (indirect holdings)

DIXON DONALD R sold 40,000 indirectly-held shares of Amprius Technologies, Inc. (AMPX) at $19.13 ($0.77M total) on 2026-06-09.

Original reporting
SEC EDGAR · DIXON DONALD R
Published Jun 11, 2026, 9:56 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 11, 2026, 10:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AMPX
Neutral
high confidence
Mentioned
$AMPX
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMPXNeutralLow
01

Why it matters

Traders may monitor for follow-on insider buying/selling patterns, but the disclosure alone typically has limited price impact absent other company catalysts.

02

Market read

A director’s $765k open-market sale is disclosed; likely sentiment noise rather than a tradable fundamental catalyst.

03

What to watch

No 10b5-1 plan is stated, but the article provides no context on taxes, planned liquidity needs, or whether other insiders/owners are buying.

Relevance 5/10Novelty 2/10Timing: Filed 2026-06-11 for a sale dated 2026-06-09

Background

This is an SEC Form 4 insider transaction disclosure for Amprius Technologies (AMPX).

Company-level read

Ticker impact

$AMPXNeutralHigh confidence
Context

Amprius Technologies director Dixon Donald R sold 40,000 shares in an open-market transaction worth $765,200, filed as a Form 4.

Expected impact

Low near-term impact; any effect is likely sentiment-only unless followed by additional insider activity or company-specific news.

Evidence & confidence

The filing is an insider transaction with no 10b5-1 plan and no accompanying company event (earnings, guidance, contract, or enforcement) in the provided text.

Market effects

Minimal; single insider sale does not reset sector expectations.

None indicated.

None indicated.

Counterpoint

The sale could be diversification or liquidity-driven rather than a bearish signal, especially with a large remaining share balance (444,380 shares after).

Key entities

  • Amprius Technologies, Inc.

    Subject of the Form 4 insider sale disclosure.

  • Dixon Donald R

    Director who sold 40,000 shares open-market on 2026-06-09.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AMPXMedAI 8/10

Amprius (AMPX) Q3 2026 Earnings Call Transcript

Amprius reported Q3 2026 revenue of $39.1M, up 83% YoY, raising its full-year target to $145M. The company introduced SiCore 500 cells for aviation and secured a $75M U.S. defense contract. Amprius expanded into maritime vehicles and partnered with U.S. manufacturers for NDAA-compliant production.

$AMPXMedAI 8/10

Amprius Technologies Q3 Earnings Call Highlights

Amprius reported a Q3 net loss of $3.5M, with adjusted EBITDA at -$1M. The company maintained its full-year gross margin forecast of 28% and expects Q4 sales of $43.3M. Amprius is expanding manufacturing to meet demand, with a $75M contract for a U.S. battery production line. It also introduced new products for aviation and deep-sea applications, ending Q3 with $60.7M in cash.

$AMPXHigh

Amprius Technologies falls 7% on third quarter earnings miss

Amprius Technologies (NYSE:AMPX) reported Q3 earnings missing estimates with a loss of $0.02 per share, though revenue of $39.1M beat expectations. Shares fell 7.7% after-hours. The company raised its full-year 2026 revenue outlook to $145M, above analyst forecasts. Gross profit rose 217% YoY to $10.5M, with gross margin improving to 27%. Amprius secured a $75M U.S. Department of War contract and introduced a new battery cell.

$AMPXMed

Amprius Technologies Reports Third Quarter 2026 Financial Results and Recent

Amprius Technologies, Inc. (AMPX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Amprius Technologies Reports Third Quarter 2026 Financial Results and Recent Business Highlights • Q3 2026 revenue increased 83% year-over-year to $39.1 million • Net loss of $3.5 million, a 10% year-over-year improvement • Increasing 2026 revenue outlook to $145 mil

$AMPXHigh

AMPX Stock Jumps As Defense Deals Supercharge Growth Story

Amprius Technologies Inc. (NYSE: AMPX) shares rose 8.38% on October 21, 2026, driven by U.S. Department of War funding and a partnership with Caminus for battery production. The company secured $75M in funding for a high-energy-density cell plant, with revenue growth but negative margins. Canaccord Genuity initiated coverage with a Buy rating and $14 price target.